EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review

Ling Zhu, Ke Yi, Jieyi Zhou, Guanqian Hu, Jie He, Hongyan Lan, Miaomiao Chen, Lin Sun, Bo Zheng, Rong Li

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06680-9 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2025. Verfasst von Ling Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Navy Medical Center of PLA, Naval Medical University, Huaihai West Road No. 338, Shanghai, 200050, China. Hauptthemen laut MEDLINE: Blast Crisis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Fusion Proteins, bcr-abl, Nuclear Proteins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission Talent Plan Youth Project, Sanhang Talent program of Naval medical university.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extramedullary blast crisis (EMBC) is rare, clinically heterogeneous, and often misdiagnosed because routine histology may be inconclusive. We describe a CML-EMBC case in which targeted RNA sequencing uncovered concurrent NPM1::CCDC28A and BCR::ABL1 fusions, refining the diagnosis and suggesting a novel molecular subset.Clinical, laboratory, imaging, histopathology, and outcome data of a 26-year-old man were reviewed retrospectively. Targeted RNA-seq was performed on formalin-fixed, paraffin-embedded sacrococcygeal tissue. PubMed and Google Scholar were searched with "NPM1," "CCDC28A," "fusion," "CML," "myeloid sarcoma," and "extramedullary blast crisis" to contextualise NPM1 rearrangements. The patient achieved deep molecular remission of chronic-phase CML (BCR::ABL1 0.0058% International Scale) while receiving flumatinib, yet developed a painful sacrococcygeal mass. Initial biopsy suggested an undifferentiated small round-cell sarcoma. RNA-seq revealed dual NPM1::CCDC28A and BCR::ABL1 fusions, prompting reclassification as granulocytic sarcoma-type CML-EMBC. Intermediate-dose cytarabine with continued tyrosine-kinase inhibition produced marked metabolic regression on PET-CT, and the patient has been bridged to allogeneic hematopoietic stem-cell transplantation. Literature review uncovered only sporadic reports of NPM1::CCDC28A; experimental data indicate that the fusion up-regulates HOX clusters similarly to mutant NPM1, facilitating leukemogenesis and extramedullary dissemination. Solitary tumours in CML patients who are in marrow remission should prompt suspicion for EMBC. When morphology is ambiguous, integrating molecular pathology, particularly targeted RNA-seq, can confirm myeloid lineage and uncover disease-relevant alterations. Co-occurrence of BCR::ABL1 and NPM1::CCDC28A may delineate a distinct EMBC subset with prognostic and therapeutic relevance. Prospective studies are required to clarify the fusion's pathogenic role and biomarker potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blast CrisisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFusion Proteins, bcr-ablNuclear ProteinsHumansNucleophosminMaleAdultOncogene Proteins, Fusion

Stichwörter der Autor:innen

Case reportChronic myeloid leukemiaExtramedullary blast crisisGranulocytic sarcomaMolecular diagnosisNPM1:CCDC28A

Substanzen

NucleophosminNPM1 protein, humanFusion Proteins, bcr-ablNuclear ProteinsOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Hematology, Navy Medical Center of PLA, Naval Medical University, Huaihai West Road No. 338, Shanghai, 200050, China.
  • Department of Hematology, Navy Medical Center of PLA, Naval Medical University, Huaihai West Road No. 338, Shanghai, 200050, China. bozheng0923@qq.com.
  • Department of Hematology, Navy Medical Center of PLA, Naval Medical University, Huaihai West Road No. 338, Shanghai, 200050, China. lirong785@hotmail.com.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission Talent Plan Youth Project
  • Sanhang Talent program of Naval medical university

Zitieren

APA

Zhu, L., Yi, K., Zhou, J., Hu, G., He, J., Lan, H., Chen, M., Sun, L., Zheng, B., & Li, R. (2025). Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review. Annals of Hematology. https://doi.org/10.1007/s00277-025-06680-9

Vancouver

Zhu L, Yi K, Zhou J, Hu G, He J, Lan H, et al. Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review. Annals of Hematology. 2025. doi:10.1007/s00277-025-06680-9

BibTeX
@article{Zhu2025,
  author = {Zhu, Ling and Yi, Ke and Zhou, Jieyi and Hu, Guanqian and He, Jie and Lan, Hongyan and Chen, Miaomiao and Sun, Lin and Zheng, Bo and Li, Rong},
  title = {Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06680-9}
}
Kostenlos starten →